Trademarkia Logo

Canada

C$
LYFGENIA
WITHDRAWN BY OWNER

on 8 Apr 2022

Last Applicant/ Owned by

BLUEBIRD BIO INC.

60 Binney StreetCambridge MA 02142

US

Serial Number

2108286 filed on 26th Feb 2021

LYFGENIA

Trademark usage description

pharmaceutical preparations and substances for use in gene therapy, namely for treatment of sickle cell disease.

Classification Information


Class [005]
Pharmaceutical preparations and substances for use in gene therapy, namely for treatment of sickle cell disease.


Classification kind code

11

Mark Details


Serial Number

2108286

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 5
on 8th Apr 2022
Withdrawn by Owner
Submitted for opposition 256
on 21st Mar 2022
Notification of Possible Opposition Sent
Submitted for opposition 80
on 19th Jan 2022
Change of Title Registered
Submitted for opposition 234
on 14th Jul 2021
Partial Ceasing of Effect Received - No Amendments Required
Submitted for opposition 231
on 27th May 2021
Limitation
Submitted for opposition 257
on 20th May 2021
Designation Notification - Madrid Protocol
Submitted for opposition 31
on 19th May 2021
Formalized
Submitted for opposition 1
on 19th May 2021
Created
Submitted for opposition 228
on 26th Feb 2021
International Registration
Submitted for opposition 30
on 26th Feb 2021
Filed